Trial | NCT00346827  Report issue

Title

Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

  • Phase

    Phase 2/Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    apomorphine ...

  • Study Participants

    36
To determine the safety and tolerability of repeated dosing with Apomorphine Nasal Powder in subjects with Parkinson's Disease.
Study Started
Jul 31
2006
Primary Completion
Aug 31
2007
Study Completion
Aug 31
2007
Last Update
Jul 10
2019

Drug Apomorphine Nasal Powder

Criteria 

Inclusion Criteria:

1 year history of Parkinson's Disease; stable PD medications for 4 weeks; at least one documented "off" period per day

Exclusion Criteria:

hypersensitivity to apomorphine; participation in a clinical trial in the last 12 weeks; pregnant or lactating females
No Results Posted